A randomized study of contingency management in cocaine-dependent patients with severe and persistent mental health disorders

Drug and Alcohol Dependence

Volumn 130, Issue 1-3, 2013, Pages 234-237

  Petry, Nancy M ^a   Alessi, Sheila M ^a   Rash, Carla J ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Bipolar disorder; Cocaine dependence; Contingency management; Depression; Dual diagnosis; Schizophrenia

Indexed keywords

ABSTINENCE; ADULT; ARTICLE; CLINICAL ARTICLE; COCAINE DEPENDENCE; COMMUNITY MENTAL HEALTH; CONTINGENCY MANAGEMENT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; MALE; MANAGEMENT; MEDICAL HISTORY; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; URINALYSIS;

ADULT; COCAINE-RELATED DISORDERS; DISEASE MANAGEMENT; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84877041589     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.10.017     Document Type: Article

References (35)

1. Andrade L.F., Alessi S.M., Petry N.M. The impact of contingency management on quality of life among cocaine abusers with and without alcohol dependence. Am. J. Addict. 2012, 21:47-54.
2. Bellack A.S., Bennett M.E., Gearon J.S., Brown C.H., Yang Y. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Arch. Gen. Psychiatry 2006, 63:426-432.
3. Beutler L.E., Engle D., Mohr D., Daldrup R.J., Bergan J., Meredith K., Merry W. Predictors of differential response to cognitive, experiential, and self-directed psycho-therapeutic procedures. J. Consult. Clin. Psychol. 1991, 59:333-340.
4. Derogatis L.R. The Brief Symptom Inventory (BSI): Administration Scoring Procedures Manual-II 1993, Clinical Psychometric Research, Minneapolis, MN.
5. Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr. Res. 1999, 35(Suppl.):S93-S100.
6. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for the DSM-IV-TR Axis I Disorders Clinician Version 1996, American Psychiatric Association, Washington, DC.
7. Ghitza U.E., Epstein D.H., Preston K.L. Contingency management reduces injection-related HIV risk behaviors in heroin and cocaine using outpatients. Addict. Behav. 2008, 33:593-604.
8. Hanson T., Alessi S.M., Petry N.M. Contingency management reduces drug-related human immunodeficiency virus risk behaviors in cocaine-abusing methadone patients. Addiction 2008, 103:1187-1197.
9. Higgins S.T., Sigmon S.C., Wong C.J., Heil S.H., Badger G.J., Donham R., Dantona R.L., Anthony S. Community reinforcement therapy for cocaine-dependent outpatients. Arch. Gen. Psychiatry 2003, 60:1043-1052.
10. Higgins S.T., Heil S.H., Dantona R., Donham R., Matthews M., Badger G.J. Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients. Addiction 2007, 102:271-281.
11. Lussier J.P., Heil S.H., Mongeon J.A., Badger G.J., Higgins S.T. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006, 101:192-203.
12. Mueser K.T., Yarnold P.R., Bellack A.S. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatr. Scand. 1992, 85:48-55.
13. Mullen P.E., Burgess P., Wallace C., Palmer S., Ruschena D. Community care and criminal offending in schizophrenia. Lancet 2000, 355:614-617.
14. Olfson M., Mechanic D., Hansell S., Boyer C.A., Walkup J., Welden P.J. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr. Serv. 2000, 51:216-222.
15. Owen R.R., Fischer E.P., Booth B.M., Cuffel B.J. Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatr. Serv. 1996, 47:853-858.
16. Peirce J.M., Petry N.M., Stitzer M.L., Blaine J., Kellogg S., Satterfield F., Schwartz M., Krasnansky J., Pencer E., Silva-Vasquez L., Kirby K.C., Royer-Malvestuto C., Roll J.M., Cohen A., Copersino M.L., Kolodner K., Li R. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch. Gen. Psychiatry 2006, 63:201-208.
17. Petry N.M., Alessi S.M., Hanson T., Sierra S. Randomized trial of contingent prizes versus vouchers in cocaine-using methadone patients. J. Consult. Clin. Psychol. 2007, 75:983-991.
18. Petry N.M., Alessi S.M., Hanson T. Contingency management improves abstinence and quality of life in substance abusers. J. Consult. Clin. Psychol. 2007, 75:307-315.
19. Petry N.M., Alessi S.M., Marx J., Austin M., Tardif M. Vouchers versus prizes: contingency management treatment of substance abusers in community settings. J. Consult. Clin. Psychol. 2005, 73:1005-1014.
20. Petry N.M., Barry D., Alessi S.M., Rounsaville B.J., Carroll K.M. A randomized trial adapting contingency management targets based on initial abstinence status of cocaine-dependent patients. J. Consult. Clin. Psychol. 2012, 80:276-285.
21. Petry N.M., Kolodner K.B., Li R., Peirce J.M., Roll J.M., Stitzer M.L., Hamilton J.A. Prize-based contingency management does not increase gambling. Drug Alcohol Depend. 2006, 83:269-273.
22. Petry N.M., Martin B., Simcic F. Prize reinforcement contingency management for cocaine dependence: integration with group therapy in a methadone clinic. J. Consult. Clin. Psychol. 2005, 73:354-359.
23. Petry N.M., Peirce J.M., Stitzer M.L., Blaine J., Roll J.M., Cohen A., Obert J., Killeen T., Saladin M.E., Cowell M., Kirby K.C., Sterling R., Royer-Malvestuto C., Hamilton J., Booth R.E., Macdonald M., Liebert M., Rader L., Burns R., DiMaria J., Copersino M., Stabile P.Q., Kolodner K., Li R. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a National Drug Abuse Treatment Clinical Trials Network study. Arch. Gen. Psychiatry 2005, 62:1148-1156.
24. Petry, N.M., Rash, C.J., Alessi, S.M. Contingency management for drug abuse decreases psychiatric symptoms, submitted for publication.
25. Petry N.M., Rash C.J., Byrne S., Ashraf S., White W.B. Financial reinforcers for improving medication adherence: findings from a meta-analysis. Am. J. Med. 2012, 125:888-896.
26. Petry N.M., Tedford J., Austin M., Nich C., Carroll K.M., Rounsaville B.J. Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom?. Addiction 2004, 99:349-360.
27. Prendergast M., Podus D., Finney J., Greenwell L., Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 2006, 101:1546-1560.
28. Ries R.K., Dyck D.G., Short R., Srebnik D., Fisher A., Comtois K.A. Outcomes of managing disability benefits among patients with substance dependence and severe mental illness. Psychiatr. Serv. 2004, 55:445-447.
29. Roll J.M., Chermack S.T., Chudzynski J.E. Investigating the use of contingency management in the treatment of cocaine abuse among individuals with schizophrenia: a feasibility study. Psychiatry Res. 2004, 125:61-64.
30. Shaner A., Khalsa M.E., Roberts L., Wilkins J., Anglin D., Hsieh S.C. Unrecognized cocaine use among schizophrenic patients. Am. J. Psychiatry 1993, 150:758-762.
31. Sigmon S.C., Higgins S.T. Voucher-based contingent reinforcement of marijuana abstinence among individuals with serious mental illness. J. Subst. Abuse Treat. 2006, 30:291-295.
32. Sigmon S.C., Steingard S., Badger G.J., Anthony S.L., Higgins S.T. Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study. Exp. Clin. Psychopharmacol. 2000, 8:509-517.
33. Stitzer M.L., Petry N.M., Peirce J., Kirby K., Killeen T., Roll J., Hamilton J., Stabile P.Q., Brown C., Kolodner K., Li R. Effectiveness of abstinence-based incentives: interaction with intake stimulant test results. J. Consult. Clin. Psychol. 2007, 75:805-811.
34. Swartz M.S., Miller D.D., Wagner H.R., Reimherr F., Swanson J.W., Khan A., Stroup T.S., Canive J.M., McEvoy J.P., Lieberman J.A., McGee M. Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE study. Psychiatr. Serv. 2006, 57:1110-1116.
35. Wallace C., Mullen P.E., Burgess P. Criminal offending in schizophrenia over a 25-year period marked by deinstitutionalization and increasing prevalence of comorbid substance use disorders. Am. J. Psychiatry 2004, 161:716-727.